Uncategorised - European Medical Journal

Dual Index Approach Enhances Detection of Functional Decline in Patients on Haemodialysis

A new study highlights how combining the Geriatric Nutritional Risk Index (GNRI) and Modified Creatinine Index (mCI) significantly improves prediction of functional dependence in hemodialysis patients.

Psychiatric Symptoms Foretell Alzheimer's Progression

Persistent neuropsychiatric symptoms (NPS) in older adults could serve as early warning signs of underlying Alzheimer’s disease (AD) pathology, according to new research.

New Emulsion Outperforms Petrolatum in Childhood Eczema

Results revealed that the group using partially myristoylated carboxymethyl chitosan emulsion experienced a significantly greater reduction in EASI scores.

Genetic Clues Behind P. aeruginosa Drug Resistance

Pseudomonas aeruginosa, a leading cause of microbial keratitis, continues to challenge clinicians with rising antimicrobial resistance.

Assessing Protein Needs in Older Adults with Sarcopenia Through Urine Test

This pioneering study provides valuable insights into dietary assessment techniques in older adults with sarcopenia.

Varenicline Helps Young People Quit Vaping in Landmark Trial

Youth using varenicline with brief behavioral support were far more likely to quit vaping than those given placebo or usual care, a new randomized trial finds.

Calcified Lesions: AI-Driven μQFR Offers Viable Alternative to Fractional Flow Reserve

μQFR shows moderate accuracy for calcified coronary lesions, offering a wire-free FFR alternative.

Amyloid PET Scans Can Predict Cognitive Decline in Early-Stage Memory Concerns

A European study reveals that even low levels of brain amyloid detected by PET scans can signal future Alzheimer’s risk in individuals reporting memory concerns.

Higher eGDR May Signal Lower Mortality in Diabetes

Higher eGDR linked with lower mortality and cardiovascular risk in diabetes, offering promise for clinical risk stratification.

New Treatment Cuts Exacerbations in Bronchiectasis

Targeting inflammation at its root, a new therapy reduces bronchiectasis exacerbations and slows lung function decline, according to results from a Phase III clinical trial.